PT - JOURNAL ARTICLE AU - Abu-Raddad, Laith J. AU - Chemaitelly, Hiam AU - Ayoub, Houssein H. AU - Tang, Patrick AU - Coyle, Peter AU - Hasan, Mohammad R. AU - Yassine, Hadi M. AU - Benslimane, Fatiha M. AU - Al Khatib, Hebah A. AU - Kanaani, Zaina Al AU - Kuwari, Einas Al AU - Jeremijenko, Andrew AU - Kaleeckal, Anvar Hassan AU - Latif, Ali Nizar AU - Shaik, Riyazuddin Mohammad AU - Abdul Rahim, Hanan F. AU - Nasrallah, Gheyath K. AU - Al Kuwari, Mohamed Ghaith AU - Butt, Adeel A. AU - Al Romaihi, Hamad Eid AU - Khal, Abdullatif Al AU - Al-Thani, Mohamed H. AU - Bertollini, Roberto TI - Effect of vaccination and of prior infection on infectiousness of vaccine breakthrough infections and reinfections AID - 10.1101/2021.07.28.21261086 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.28.21261086 4099 - http://medrxiv.org/content/early/2021/07/30/2021.07.28.21261086.short 4100 - http://medrxiv.org/content/early/2021/07/30/2021.07.28.21261086.full AB - SARS-CoV-2 breakthrough infections in vaccinated individuals and in those who had a prior infection have been observed globally, but the transmission potential of these infections is unknown. The RT-qPCR cycle threshold (Ct) value is inversely correlated with viral load and culturable virus. Here, we investigated differences in RT-qPCR Ct values across Qatar’s national cohorts of primary infections, reinfections, BNT162b2 (Pfizer-BioNTech) breakthrough infections, and mRNA-1273 (Moderna) breakthrough infections. Through matched-cohort analyses of the randomly diagnosed infections, the mean Ct value was higher in all cohorts of breakthrough infections compared to the cohort of primary infections in unvaccinated individuals. The Ct value was 1.3 (95% CI: 0.9-1.8) cycles higher for BNT162b2 breakthrough infections, 3.2 (95% CI: 1.8-4.5) cycles higher for mRNA-1273 breakthrough infections, and 4.0 (95% CI: 3.4-4.6) cycles higher for reinfections in unvaccinated individuals. Assuming a linear relationship between viral load and infectiousness, these differences imply that breakthrough infections are at least 50% less infectious than primary infections in unvaccinated individuals. Public health benefits of vaccination may have been underestimated, as COVID-19 vaccines not only protect against acquisition of infection, but also appear to protect against transmission of infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors are grateful for support from the Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core, both at Weill Cornell Medicine-Qatar, as well as for support provided by the Ministry of Public Health and Hamad Medical Corporation. The authors are also grateful for the Qatar Genome Programme for supporting the viral genome sequencing. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the article. Statements made herein are solely the responsibility of the authors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Hamad Medical Corporation and Weill Cornell Medicine-Qatar Institutional Review Boards with waiver of informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset of this study is a property of the Qatar Ministry of Public Health that was provided to the researchers through a restricted-access agreement that prevents sharing the dataset with a third party or publicly. Future access to this dataset can be considered through a direct application for data access to Her Excellency the Minister of Public Health (https://www.moph.gov.qa/english/Pages/default.aspx). Aggregate data are available within the manuscript and its Supplementary information.